A ngiogenesis, the formation of new blood vessels from preexisting vasculature, mediates delivery of nutrients and oxygen to developing organs while removing metabolic waste products. Angiogenesis requires selection of endothelial tip cells by a gradient of VEGF (vascular endothelial growth factor) from the parent vessels, directional migration, and the establishment of connections between new sprouts.
1,2 Two major signaling pathways, VEGFR and Notch, fine-tune angiogenic sprouting in a reciprocal manner. [3] [4] [5] Editorial, see p 1690
In mammals, the Notch family comprises 2 Jagged-like ligands 1-2, 3 delta-like ligands (DLL1, 3, and 4), and 4 Notch receptors (Notch1-4). [6] [7] [8] The role of DLL4 and Jagged-like ligands 1 during angiogenesis have been well-studied, with DLL4 inhibiting and Jagged-like ligands 1 promoting angiogenesis under most developmental or pathological conditions. [9] [10] [11] [12] DLL4 is abundant in filopodia-rich tip cells, which respond to surrounding molecular cues. The DLL4 expression, triggered by VEGF, 11, 13 activates Notch signaling and suppresses the tip cell phenotype in the neighboring stalk cells. Moreover, DLL4 expression is also induced by Notch, 12, 14 which may be a signal-relay mechanism that maintains the stalk cell fate. Notch activation involves a disintegrin and metalloprotease-mediated cleavage at the S2 site and γ-secretasemediated cleavage at the S3 site of the Notch receptor, generating Notch intracellular domain (NICD), which enters the nucleus to transactivate downstream Notch target gene expression. [15] [16] [17] Notch activation downregulates VEGFR2 (vascular endothelial growth factor receptor-2) expression, whereas its suppression augments VEGFR2 signaling and accelerates blood vessel sprouting and branching. 6, 9, [18] [19] [20] [21] [22] Our recent study uncovered a previously unrecognized connection between cholesterol metabolism and blood vessel formation in zebra fish. Cholesterol transport requires cholesterol transporters ATP-binding cassette (ABC) family members ABCA1 and ABCG1; ABCA1 mediates cholesterol efflux to the lipid-poor cholesterol acceptor apolipoprotein A-I (apoA-I), yielding a nascent high-density lipoprotein (HDL), while ABCG1 mediates cholesterol efflux to mature HDL. [23] [24] [25] [26] We showed that spatiotemporal expression of AIBP (apoA-Ibinding protein) restrains and guides angiogenesis in embryonic zebra fish. Mechanistically, AIBP accelerates cholesterol efflux from endothelial cells (ECs) to HDL, which in turn reduces the amount of plasma membrane cholesterol available for lipid raft formation, thereby impairing VEGFR2 signaling competence. 27 Extracellular AIBP promotes cholesterol efflux from human macrophages, thereby reducing lipid accretion. 28 AIBP, encoded by the Apoa1bp gene in mice and APOA1BP gene in humans, is a secreted protein that physically associates with apoA-I 29 ; AIBP is ubiquitously expressed and abundant in most human organs with secretory functions. Of note, AIBP is not expressed in the skeletal muscle but is highly expressed in vascular smooth muscle cells and in heart muscle, 30 which implicates AIBP in cardiovascular functions. AIBP is evolutionarily conserved from Drosophila to human, 29, 31 and thus, we propose that the role of AIBP in angiogenesis is also conserved from zebra fish to mice to humans. Importantly, understanding the molecular mechanism for AIBP-regulated angiogenesis may guide the development of novel therapeutic strategies targeting angiogenesis in different pathological settings. To this end, we generated Apoa1bp −/− mice, with which we discovered a new mechanistic underpinning of AIBPregulated angiogenesis, which downregulates Notch in a γ-secretase-dependent fashion and restricts murine retinal and pathological angiogenesis. Importantly, loss of AIBP accelerates angiogenesis without affecting the integrity and functionality of blood vessels, suggesting that AIBP is a potential pharmacological target for treating cardiovascular disease.
Methods

Preparation of Whole Mount Retinas
After euthanization, eyes of neonatal mice at the appropriate developmental stage were isolated, fixed in 4% paraformaldehyde (PFA), and dissected. Retinal cups were subjected to immunostaining with the indicated Abs or extraction of total RNA or proteins as described below.
In Situ Hybridization
Murine retinas were incubated sequentially in 15% sucrose-PBS, 30% sucrose-PBS, and optimal cutting temperature compound and then used to prepare 5-μm-thick sections. After fixation in 4% PFA and acetylation in 1% triethanolamine and 0.25% acetic anhydride, the slides were prehybridized and incubated overnight with hybridization solution containing the RNA probes at 65°C. Subsequently, the sections were washed and probed with AP-conjugated anti-DIG Ab or anti-fluorescein Ab. 
Novelty and Significance
What Is Known?
• Increased blood vessel formation after cardiac ischemia contributes to improved cardiac recovery.
• AIBP (apolipoprotein A-I-binding protein), a secreted protein, accelerates cholesterol efflux from endothelial cells, disrupts lipid rafts, and impairs raft-associated VEGFR2 (vascular endothelial growth factor receptor-2) signaling, thereby restricting angiogenesis.
• Notch signaling counteracts VEGFR2 signaling, inhibits angiogenesis, and stabilizes blood vessels.
• Notch activation entails its cleavage by γ-secretase, release of the intracellular domain, and activation of a transcriptional program.
What New Information Does This Article Contribute?
• AIBP-mediated disruption of lipid rafts relocates Notch1 and γ-secretase from lipid rafts to nonraft domains.
• Increased localization of Notch1 and γ-secretase in the nonraft domains facilitates Notch1 cleavage and its activation.
• AIBP deficiency in mice attenuates Notch signaling.
• AIBP knockout augments retinal and pathological angiogenesis in mice.
• Expression level of AIBP in the heart is increased in patients with ischemic cardiomyopathy.
Angiogenesis is essential for tissue remodeling and repair after cardiac ischemia. Treatments that improve blood vessel formation holds great promise for patients with coronary artery disease. We previously found that the secreted protein, AIBP, limits angiogenesis via modulation of cholesterol metabolism. In this article, we generated AIBP knockout mice and found that, consistent with our prior study, loss of AIBP increased developmental retinal angiogenesis and pathological angiogenesis in a murine hindlimb ischemia model. Furthermore, we showed that cardiac AIBP expression is increased in human ischemic cardiomyopathy. 
Hematoxylin and Eosin and Immunohistochemistry
The PFA-fixed Matrigel plug was washed in PBS and then embedded in paraffin. Five-micrometer sections were prepared and deparaffinized by sequential incubation in xylene and ethanol. After rehydration, the slides were stained with hematoxylin and eosin following a standard protocol. For immunohistochemistry staining of Matrigel plugs harvested from the mice, 5-μm-thick paraffin sections were deparaffinized, hydrated, and boiled in 10 mmol/L sodium citrate buffer (pH 6.0) for 15 minutes to facilitate antigen retrieval. After a brief treatment with Background Buster Blocking Agent (Innovex Biosciences), the slides were incubated with the primary antibody for 45 minutes. After washing, the slides were incubated sequentially with STAT-Q secondary linking antibodies (Innovex Biosciences), HRP (horseradish peroxidase)-labeled streptavidin and Innovex substrate (DAB [3,3'-diaminobenzidine tetrahydrochloride]) for color development following the manufacturer's instructions.
DLL4-Induced NICD Production
Human retinal ECs were plated and kept in culture for 4 hours onto 6-well plates that were precoated with or without recombinant human DLL4 protein (0.5 μg/mL) in 0.1% BSA/PBS for 1 hour at room temperature. Cells were further incubated with AIBP (0.1 μg/ mL), HDL 3 (50 μg /mL), or their combination for 4 hours, with 20
γ-secretase inhibitor) for 24 hours, 10 mmol/L methyl-β-cyclodextrin (MβCD) for 10 minutes, or 10 μg/ mL water-soluble cholesterol (Sigma) for 2 hours. After the various treatments, cells were washed with PBS and lysed. The NICD levels were assessed by Western blot using a γ-secretase cleavage-specific antibody Val1744 (Cell Signaling Technology).
Results
AIBP Expression in the Retinal Ganglion Cells
Apoa1bp-null mice were generated as described (Online Figure  IA) ; polymerase chain reaction and Western blot analysis indicated the absence of AIBP (Online Figure IB through ID) . AIBP-null mice are viable and fertile and have no apparent morphological defects compared with control mice under naïve conditions. Our study in zebra fish showed that Aibp functions noncell autonomously in angiogenesis 27 and that the tissue localization of Aibp at 24 hours post-fertilization is similar to that of Sema 3a. 33 To assess the mRNA localization of murine Apoa1bp, in situ hybridization was performed on adjacent sections through postnatal day 5 (P5) murine retinas for Apoa1bp and Brn3b, a retinal ganglion cell marker. As with our study in zebra fish, Apoa1bp mRNA was localized in the Brn3b-positive retinal ganglion cell layer of a murine retina (Online Figure II) , which expresses Sema3E. 34 As expected, the Apoa1bp mRNA signal was absent in the Apoa1bp knockout retina (Online Figure IIA and IIC). AIBP expression in retinal ganglion cell implies a paracrine role of AIBP in murine retinal angiogenesis.
Loss of AIBP Increases Murine Retinal Angiogenesis
We assessed AIBP function in the retinal vasculature. The murine retina is avascular at birth; starting from postnatal day 1 (P1), a single superficial layer of blood vessels extends radially outwards from the center vessels at the optical nerve head toward the periphery until P7. 35 Whole-mount immunofluorescent staining of the isolated retinas was performed with CD31 and Collagen IV on P5 retinas. AIBP-deficient retinas at P5 showed a profound increase in the radial extension of vascular plexus from the optic nerve to the periphery ( Figure 1A and 1B) and in the total vascular area ( Figure 1A and 1C). Next, we analyzed the branch points in Apoa1bp −/− and control littermates because extensive remodeling and sprouting is required to establish an interconnected vasculature network. The front and center areas analyzed in the retinas are illustrated in Figure 1D . Consistent with a role for AIBP in retinal angiogenesis, more branch points were observed in both front and central areas of the vascular plexus in the Apoa1bp −/− retinas compared with control littermate retinas ( Figure 1E through 1G). Similar results were obtained in P3 neonates' retinas (Online Figure  IIIA) . During angiogenesis, tip cells manifest exploratory and sprouting behavior by extending numerous filopodia. 1 More endothelial tip cells were observed in AIBP null retinas than that in control littermates ( Figure 2H and 2I) , and the number of filopodia was significantly increased in Apoa1bp −/− retinas ( Figure 1J and 1K) . However, loss of AIBP had no effect on blood vessel formation at P7 and P9 (Online Figure IIIB and IIIC), which indicates that AIBP disruption accelerates normal retinal angiogenesis. The difference in angiogenesis may be caused by change in vessel stability. Thus, we stained for Collagen IV because regressed vessels generally leave empty sleeves of collagen IV-rich matrix deposits and which are used for the assessment of vessel stability. 36 There was no apparent difference in vessel stability because similar numbers of empty sleeves (Col IV + CD31 − ) were found in the AIBP knockout and control mice (Online Figure IVA and IVB) . Collectively, AIBP deficiency in mice results in significantly accelerated angiogenesis as evidenced by a greater radial extension length of vascular plexus, the development of a denser upper capillary layer, and a higher number of tip cells, as well as filopodia, in the retinas. This phenotype is, however, normalized by P7.
AIBP Controls Notch Signaling in Murine Retinas
Given that Notch signaling suppresses angiogenesis in most vascular beds, 37, 38 we determined whether accelerated retinal May 26, 2017
angiogenesis in Apoa1bp −/− mice was because of impaired Notch activity. The activation of the Notch pathway was markedly attenuated as evidenced by diminished production of NICD levels in Apoa1bp −/− retinas (Figure 2A and 2B). Expression of Hey1, a transcriptional repressor of Notch that is selectively expressed in the blood vessels during retinal angiogenesis, 6 ,39 Hey2, and We have previously shown that AIBP controls angiogenesis via a direct effect on VEGFR2 localization to cholesterol-rich lipid rafts. 27 To distinguish the role of AIBP in VEGFR2 and Notch pathways, control and Apoa1bp −/− mice were treated with the Notch inhibitor DAPT, and retinal angiogenesis was assessed. DAPT inhibited retinal angiogenesis in Apoa1bp −/− mice to a significantly lesser degree than in control mice (Online Figure   VI) . These data indicate that AIBP regulates retinal angiogenesis through both Notch-dependent and -independent pathways.
AIBP Exerts Its Effect via γ-Secretase-Regulated Notch Signaling
Binding of a Notch ligand to a Notch receptor initiates 2 cleavage steps that generate transcriptionally active NICD-the first step mediated by a disintegrin and metalloprotease and the second by γ-secretase. 40 Because AIBP deficiency has no effect on Notch1 protein levels (Online Figure VC and VD) , and our previous studies showed that AIBP-mediated depletion of cholesterol disrupts lipid rafts, 27 we tested whether AIBP exerts its effect on γ-secretase-regulated Notch via alteration of lipid rafts. The γ-secretase complex, which includes the 4 proteins presenilin1, nicastrin, anterior pharynx defective 1, and presenilin enhancer 2, [41] [42] [43] is localized to plasma membrane lipid rafts. Disruption of lipid rafts by modest cholesterol reduction induces γ-secretase translocation from lipid rafts to nonrafts, which augments the cleavage of its substrate, APP (amyloid precursor protein), in neurons. 44 Therefore, we postulated that AIBP-mediated reduction of lipid raft abundance also enhances Notch cleavage via effects on γ-secretase distribution in ECs. We reasoned that AIBP may interact with cells to achieve an effect on lipid rafts. Thus, we verified the binding of AIBP to human retinal microvascular ECs (Online Figure VII) . Next, we performed detergent-free, discontinuous gradient ultracentrifugation analysis of human retinal microvascular ECs treated with control media, AIBP, HDL 3 , or their combination and found that coincubation with AIBP and HDL 3 translocated γ-secretase and Notch1 from lipid rafts to nonraft domains ( Figure 3A) . A, The distribution of γ-secretase and Notch1 in lipid rafts (fractions 4-6) and nonlipid rafts (fractions 9-11). Human retinal microvascular ECs (HRMECs) were incubated with 0.1 μg/mL AIBP, 50 μg/mL HDL 3 , or their combination for 4 hours and were disrupted and separated into lipid raft and nonlipid raft fractions by ultracentrifugation. Immunoblots of presenilin1 (PS1) and Notch1 were shown. B, Methyl-β-cyclodextrin (MβCD) effect on Notch activation. HRMECs were seeded onto a 6-well plate precoated with or without 0.5 μg/mL recombinant delta-like ligand 4 (DLL4) and followed by treatment with 10 mmol/L MβCD for the indicated times. To ensure cells received equal DLL4 stimulation time, the treatment was started at different time so as to harvest the cells simultaneously for immunoblotting of Notch intracellular domain (NICD). C, Quantification of NICD protein levels in B (solid line) and measurements of free cholesterol content (dash line) removed from HRMECs with MβCD treatment. D, AIBP and HDL 3 effect on Notch activation. HRMECs were seeded as in B, followed by treatment with AIBP (0.1 μg/mL), HDL 3 (50 μg/mL), AIBP/HDL 3 combination for 4 hours, with 20 μM DAPT (N-[(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycine-1,1-dimethylethyl ester; γ-secretase inhibitor) for 24 hours, with 10 mmol/L MβCD for 10 minutes or with 10 μg/mL water-soluble cholesterol for 2 hours. The different treatments were started at various time so as to lyse the cells simultaneously for Western blot of NICD. E, Quantification of NICD proteins in D. F, AIBP and HDL 3 effect on γ-secretase activity in HEK293 (human embryonic kidney) cells. HEK293 cells were transfected with NotchΔE or a control empty plasmid. After 48 hours, the resulting cells were treated as in D and used for immunoblots as indicated. NotchΔE was detected using anti-Myc Ab. G, Quantification of F. The relative values of NICD/NotchΔE/β-tubulin were normalized to that of control and the resulting numbers were used to generate the graph. Mean±SD; the experiments were done with 3 independent repeats. In all panels, **P<0.01; ***P<0.001.
Previous studies suggest that lipid rafts regulate γ-secretase. 45 Thus, we examined the effect of cholesterol on DLL4-stimulated Notch activity by incubating human retinal microvascular ECs with MβCD, an efficient cholesterol sequestrant, for 0 to 60 minutes. MβCD treatment markedly increased NICD production, peaking at 10 to 15 minutes and returning to near basal levels at 60 minutes ( Figure 3B and  3C) . As expected, the NICD levels roughly correlated with the amount of cholesterol extracted from cells by MβCD ( Figure 3C ). We next examined the effect of AIBP on DLL4-induced Notch activity in human ECs. Human retinal microvascular ECs were incubated with AIBP, HDL 3 , or both. Coincubation with AIBP and HDL 3 , but not alone, significantly increased DLL4-stimulated NICD production ( Figure 3D and 3E). In contrast, supplementation of cells with free cholesterol completely eliminated NICD generation ( Figure 3D ). As expected, the γ-secretase inhibitor DAPT abolished the production of NICD ( Figure 3D and 3E ). To further test the effect of lipid rafts on γ-secretase-mediated Notch signaling, a truncated version of Notch (NotchΔE) lacking the extracellular domain but retaining the γ-secretase cleavage site 46 was transfected into HEK293T (human embryonic kidney) cells, followed by AIBP treatment in the presence or absence of HDL 3 . We found that AIBP and HDL 3 in combination, but not alone, increased the γ-secretase-dependent generation of NICD from NotchΔE ( Figure 3F and 3G) . As in human ECs, treatment with MβCD or DAPT augmented or suppressed Notch activation, respectively ( Figure 3F and 3G) . Together, these results indicate that AIBP/HDL 3 positively regulates Notch signaling by directing γ-secretase and Notch from lipid rafts to nonlipid domains, where enhanced γ-secretasemediated Notch cleavage occurs.
Increasing HDL Levels Rescues Dysregulated Retinal Angiogenesis in AIBP Null Mice
We showed that AIBP-mediated cholesterol efflux increased Notch activity ( Figure 3B through 3G) , an effect achieved through reduction of lipid raft abundance. The apoA-I transgenic mice (Apoa1 Tg ), which have ≈2-fold higher levels of HDL cholesterol than controls, 47 were used to correct the myeloproliferative disorder caused by increased lipid rafts in mice with a deficiency of the cholesterol transporters, ABCA1 and ABCG1. 48 Therefore, we crossed Apoa1bp −/− mice with apoA-I transgenic mice to increase HDL levels in Apoa1bp −/− mice and determined the effect of increased HDL levels on dysregulated angiogenesis in Apoa1bp knockout retinas (Online Figure VIIIA 
Apoa1
Tg retinas. As illustrated in Figure 4K and 4L Figure 4M ). Increased HDL levels had no significant effect on Notch1, Notch4, Dll4, Nrarp, or Vegfa gene expression (Online Figure  VIIID) .
Vascular Permeability and Pericyte Coverage in AIBP Knockout Mice
Our data indicate that the loss of AIBP accelerates developmental angiogenesis, which might be beneficial in patients with tissue ischemia. To explore the potential of AIBP for therapeutic purposes, we determined whether loss of AIBP affects perfusion and vasculature leakage. Adequate pericyte coverage is essential for the integrity of blood vessels. Therefore, mural cell coverage of ECs was investigated by whole mount immunofluorescence staining of NG2 and CD31 in P5 retinas. We found no difference in pericyte coverage in both front and central regions of P5 retinas between Apoa1bp −/− and control littermate neonatal mice ( Figure 5A  through 5D ).
To further determine the effect of AIBP on vascular integrity in vivo, we performed fluorescein angiography on Apoa1bp −/− and control wild-type mice. Neither the Apoa1bp −/− mice nor the control wild-type littermates showed any retinal vascular leakage ( Figure 5E ). Collectively, our data suggest that loss of AIBP accelerates angiogenesis while retaining vascular integrity.
Loss of AIBP in Mice Enhances Neovascularization in the Matrigel Plug Assay and Improves Functional Recovery of the Vasculature in the Murine Hindlimb Ischemia Model
To test the effect of AIBP absence on in vivo angiogenesis under conditions simulating a pathological process, we injected Matrigel into a subcutaneous location. The Matrigel hardens into a plug, which is invaded by immune cells and becomes vascularized. This is a model of neovascularization occurring with ischemia and inflammation. Five days after injection, the Matrigel plugs were retrieved, and hematoxylin and eosin and immunohistochemistry were performed to evaluate blood vessel formation and perfusion within the plugs. As expected, there were more blood vessels in Matrigel plugs from Apoa1bp −/− mice than that from control mice (Figure 6A through 6C) . Quantitative real-time polymerase chain reaction analysis confirmed that expression of EC markers CD31 and VE (vascular endothelial)-cadherin was significantly increased in Matrigel plugs from Apoa1bp −/− mice ( Figure 6D and 6E). These data indicate that AIBP inhibits inflammatory neovascularization in mice, which agrees with the results of accelerated postnatal retinal angiogenesis. Remarkably, the effect of AIBP ablation on Matrigel neovascularization was more robust than in retinal angiogenesis, suggesting an important role of AIBP in regulation of angiogenesis under pathological conditions. Next we examined whether enhanced pathological angiogenesis in Apoa1bp −/− mice was because of attenuated Notch activity. Western blot analysis revealed significantly reduced NICD levels in Matrigel plugs from Apoa1bp −/− mice ( Figure 6F and 6G) . Moreover, expression of Notch downstream target genes Hey1, Hey2, and Hes1 was drastically reduced in Matrigel plugs from Apoa1bp −/− mice ( Figure 6H ), whereas Notch1 and Notch4, Dll4, and Nrarp mRNA levels showed no significant change (Online Figure X) . These results suggest that AIBP inhibits angiogenesis via positive regulation of Notch activity.
To further assess the role of AIBP in pathological angiogenesis, we used the murine hindlimb ischemia model. In unoperated animals, similar values of limb perfusion were observed in wild-type and AIBP knockout mice using laser Doppler imaging ( Figure 7A ). However, after induction of limb ischemia by femoral artery ligation, the increase in gastrocnemius capillary density and the recovery of limb perfusion was significantly enhanced in the AIBP knockout animals ( Figure 7A through 7D) . The results suggest that AIBP deficiency promotes functional blood vessel formation.
Increased AIBP Expression in Human Ischemic Cardiomyopathy
Augmented angiogenesis promotes cardiac recovery after ischemia. [49] [50] [51] To extend our findings on AIBP to the context of human cardiomyopathy, we analyzed AIBP expression in normal hearts or in hearts from patients with ischemic cardiomyopathy (ICM). Interestingly, AIBP expression was markedly increased in the myocardial tissue from ICM patients by comparison to that from patients without ICM (Figure 8 ). The data imply a possible role of AIBP in ICM, where increased AIBP expression may contribute to the ischemic pathophysiology.
Discussion
Here we showed that AIBP suppresses angiogenesis via enhanced Notch activity. AIBP knockout in mice increased postnatal retinal angiogenesis, augmented neovascularization in subcutaneous Matrigel plugs, and enhanced the increase in capillary density and recovery of limb perfusion in the murine hindlimb ischemia model (Figures 1, 6, and 7) . Moreover, we revealed that AIBP-triggered lipid raft content reduction enhances the codistribution of γ-secretase and Notch in nonlipid raft fraction and subsequently increases the γ-secretase-mediated cleavage of Notch1, thereby, augmenting Notch activity (Figure 3 ). Our study connects AIBPregulated cholesterol content in the plasma membrane with Notch signaling, which extends our findings in zebra fish and implies the conserved role of AIBP in angiogenesis. More importantly, we showed that loss of AIBP does not influence vascular integrity and that accelerated angiogenesis in Apoa1bp −/− mice produces functional blood vessels ( Figure 5 ). Interestingly, AIBP expression is substantially elevated in patients with ICM (Figure 8 ), suggesting that AIBP may be a novel determinant of tissue ischemia. Our findings indicate that AIBP may be a pharmacological target for cardiovascular therapeutics.
AIBP Effect on Developmental and Pathological Angiogenesis
The human APOA1BP gene is located at 1q21.2-1q22, which corresponds to the 1q21-q23 locus for familial combined hyperlipidemia, a common, multifactorial, and heterogeneous dyslipidemia predisposing individuals to premature coronary artery disease. 52 Despite this observation, there are no studies linking AIBP polymorphism with dyslipidemia or risk of cardiovascular disease. 53 Our study is the first to identify a noncell autonomous role of AIBP in angiogenesis.
Pathological angiogenesis usually recapitulates certain features of developmental angiogenesis. [54] [55] [56] In our Matrigel experiment, which simulates some aspects of pathological angiogenesis, AIBP exerted a striking effect on regulating Notch and angiogenesis ( Figure 6 ). However, the effect of AIBP on Notch in postnatal retinal angiogenesis was modest (Figure 1 ), which may be because of the more acute nature of Matrigel-induced pathological angiogenesis that amplifies the function of AIBP in regulating Notch (Figure 6 ). 
Lipid Rafts, γ-Secretase, and Notch
Lipid rafts are implicated in the regulation of γ-secretase activity, which cleaves Notch, thereby, activating its signaling. γ-Secretase seems to manifest greater activity in lipid rafts in in vitro studies 57 and facilitates the cleavage of its substrate APP. 58 On the other hand, lowering brain cholesterol levels in mice using statins increases amyloid production. 59 Further, in human patients with a genetic mutation that causes cellular cholesterol accumulation, early onset of APP aggregation is also found. 60, 61 Notably, γ-secretase is located in nonlipid raft membranes during embryonic development, but in lipid rafts in adults. 62 These 3 pieces of evidence suggest that reduction of lipid raft levels does not necessarily lead to an effect that is associated with decreased γ-secretase activity. Rather, in cultured neurons, a modest reduction of lipid raft abundance confers enhanced cleavage of APP by γ-secretase in nonraft fractions. 44 In support of this, our results indicate that AIBP/ HDL 3 treatment relocates γ-secretase from the lipid raft fractions to the nonraft fractions; this precipitates codistribution of γ-secretase with Notch1 in the nonraft fractions and enhances Notch signaling (Figure 3) . Thus, our study uncovered a new molecular mechanism by which AIBP regulates angiogenesis via its effect on γ-secretase-mediated Notch signaling. Our results suggest that AIBP acts primarily on Notch receptor proteolytic processing because quantitative real-time polymerase chain reaction and immunoblotting analysis indicated no substantial expression change of DLL4 and Notch1 in murine retinas (Online Figures V, VIIID, and X). Taken together, these results support a model in which AIBP regulates angiogenesis through its effect on γ-secretase translocation from lipid rafts to nonlipid rafts and ensuing Notch cleavage (Online Figure XI) .
AIBP-Regulated Angiogenesis and Vascular Integrity
In addition to identifying the inhibitory role of AIBP in angiogenesis, we also assessed the effect of AIBP on vascular integrity and permeability. We showed that in contrast to excessive VEGF treatment 55 or Epsin deficiency, 63 which promotes nonfunctional angiogenesis and results in a leaky vasculature, loss of AIBP augments functional vasculature formation, as illustrated by normal extent of pericyte coverage and undetectable fluorescein leakage ( Figure 5 ). Furthermore, we showed that AIBP deficiency facilitated blood vessel formation and improved the functional recovery of vasculature in a murine hindlimb ischemia model, which suggests the possibility of an AIBP-based therapy for angiogenesis-associated diseases. Given that stimulation of angiogenesis is considered beneficial for the treatment of myocardial infarction and that AIBP is markedly increased under the ICM condition (Figure 8 ), it will be interesting to determine whether targeting AIBP is salutary for ICM. 
